Myung In Pharmaceutical LTD. (KRX:317450)
South Korea flag South Korea · Delayed Price · Currency is KRW
64,800
+2,400 (3.85%)
At close: Feb 25, 2026

KRX:317450 Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
0.000.010.010.010.020.02
Debt / EBITDA Ratio
0.020.030.040.060.070.09
Debt / FCF Ratio
0.030.040.050.090.090.15
Net Debt / Equity Ratio
-0.61-0.48-0.39-0.32-0.31-0.19
Net Debt / EBITDA Ratio
-4.61-2.45-1.93-1.58-1.34-0.84
Net Debt / FCF Ratio
-8.51-3.54-2.57-2.39-1.82-1.40
Asset Turnover
-0.490.490.500.520.52
Inventory Turnover
-1.731.701.741.561.78
Quick Ratio
12.757.286.375.764.523.53
Current Ratio
14.278.657.857.155.714.73
Return on Equity (ROE)
-13.68%16.63%14.36%16.91%14.37%
Return on Assets (ROA)
-10.51%10.52%10.53%11.41%11.17%
Return on Invested Capital (ROIC)
24.34%25.70%23.54%19.48%21.07%19.55%
Return on Capital Employed (ROCE)
11.70%17.30%17.30%17.40%19.00%18.80%
Payout Ratio
15.52%8.15%30.06%19.50%23.43%43.10%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.